CUMBERLAND PHARMACEUTICALS INC (CPIX) Return on equity 2016–2025
CUMBERLAND PHARMACEUTICALS INC (CPIX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.4%FY2025 · since FY2016: -1.3% → -11.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.4% | +17.0 pp |
| FY2024 | -28.4% | -7.1 pp |
| FY2023 | -21.2% | -5.9 pp |
| FY2022 | -15.4% | -7.2 pp |
| FY2021 | -8.2% | -1.1 pp |
| FY2020 | -7.1% | -0.2 pp |
| FY2019 | -6.9% | +5.5 pp |
| FY2018 | -12.5% | -0.0 pp |
| FY2017 | -12.4% | -11.2 pp |
| FY2016 | -1.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice